Rohto Pharma (India) Private Limited Revenue and Competitors
Estimated Revenue & Valuation
- Rohto Pharma (India) Private Limited's estimated annual revenue is currently $12.3M per year.
- Rohto Pharma (India) Private Limited's estimated revenue per employee is $201,000
Employee Data
- Rohto Pharma (India) Private Limited has 61 Employees.
- Rohto Pharma (India) Private Limited grew their employee count by 13% last year.
Rohto Pharma (India) Private Limited's People
Name | Title | Email/Phone |
---|
Rohto Pharma (India) Private Limited Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $136.9M | 681 | 21% | N/A | N/A |
#2 | $37.8M | 188 | 29% | N/A | N/A |
#3 | $29.7M | 148 | -12% | N/A | N/A |
#4 | $27.7M | 138 | 5% | N/A | N/A |
#5 | $47.4M | 236 | 10% | N/A | N/A |
#6 | $53.1M | 264 | 13% | N/A | N/A |
#7 | $12.3M | 61 | 15% | N/A | N/A |
#8 | $25.7M | 128 | -1% | N/A | N/A |
#9 | $52.5M | 261 | 28% | N/A | N/A |
#10 | $28.1M | 140 | 6% | N/A | N/A |
What Is Rohto Pharma (India) Private Limited?
Rohto Pharma (India) Pvt. Ltd. is a subsidiary of ROHTO Pharmaceutical Co., Ltd. in Osaka, Japan, specialised in the wide range of business domain of Consumer Healthcare. ROHTO was established in 1899. Since then it remains as a trusted brand in Japan and Asia. Mentholatum was founded in 1889 in US. It is a century-old household name in US. Rohto Pharma (India) represents ROHTO and Mentholatum brands in the region. The some of main products of Rohto and Mentholatum brands are; EYE CARE - ROHTO V eyedrops - ROHTO C-Cube eyedrops - ROHTO Anti-bacterial eyedrops - ROHTO Kodomo eyedrops SKIN CARE - Hadalabo - OXY - Acnes LIP CARE - LipIce - Softlips - Natural Ice Gastro-Intestinal Medicines - Pansiron - Wakansen
keywords:N/AN/A
Total Funding
61
Number of Employees
$12.3M
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $11.5M | 61 | 56% | N/A |
#2 | $8M | 61 | 24% | N/A |
#3 | $11.7M | 62 | 41% | N/A |
#4 | $14M | 62 | 3% | N/A |
#5 | $9M | 64 | -30% | N/A |